Browse > Article
http://dx.doi.org/10.3339/jkspn.2010.14.1.10

Treatment of Severe Henoch-Schoenlein Purpura Nephritis in Children  

Shin, Jae-Il (The Institute of Kidney Disease, Department of Pediatrics Yonsei University College of Medicine, Severance Children's Hospital)
Lee, Jae-Seung (The Institute of Kidney Disease, Department of Pediatrics Yonsei University College of Medicine, Severance Children's Hospital)
Publication Information
Childhood Kidney Diseases / v.14, no.1, 2010 , pp. 10-21 More about this Journal
Abstract
The overall prognosis of Henoch-Schoenlein purpura (HSP) is favorable, but severe nephritis has a high risk of progression to end stage renal failure. Recent studies emphasize the importance of early treatment in children with severe HSP nephritis, but the treatment of severe HSP nephritis still remains controversial due to the rarity of randomized controlled studies in this field. Nevertheless, several intensive therapies, such as intravenous high-dose methylprednisolone pulse, immunosuppressive/cytotoxic drugs, fibrinolytic therapy, anticoagulants, antiplatelet agent and plasma exchange, have been used in children with severe HSP nephritis. In this review, we focus on the treatment of severe HSP nephritis in children.
Keywords
Henoch-Schoenlein purpura; Severe Henoch-Schoenlein purpura nephritis; Intensive therapy; Children;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Shin JI, Park JM, Shin YH, Hwang DH, Kim JH, Lee JS. Predictive factors for nephritis, relapse, and significant proteinuria in childhood Henoch-Schonlein purpura. Scand J Rheumatol 2006;35:56-60.   DOI   ScienceOn
2 Tarshish P, Bernstein J, Edelmann CM Jr. Henoch-Schonlein purpura nephritis: course of disease and efficacy of cyclophosphamide. Pediatr Nephrol 2004;19:51-6.   DOI   ScienceOn
3 Flynn JT, Smoyer WE, Bunchman TE, Kershaw DB, Sedman AB. Treatment of Henoch-Schonlein Purpura glomerulone phritis in children with high-dose corticosteroids plus oral cyclophosphamide. Am J Nephrol 2001;21:128-33.   DOI   ScienceOn
4 Singh S, Devidayal, Kumar L, Joshi K, Minz RW, Datta U. Severe Henoch-Schonlein nephritis: resolution with azathioprine and steroids. Rheumatol Int 2002;22:133-7.   DOI   ScienceOn
5 Ronkainen J, Autio-Harmainen H, Nuutinen M. Cyclosporin A for the treatment of severe Henoch-Schonlein glomerulonephritis. Pediatr Nephrol 2003;18:1138-42.   DOI   ScienceOn
6 Chang WL, Yang YH, Wang LC, Lin YT, Chiang BL. Renal manifestations in Henoch- Schonlein purpura: a 10-year clinical study. Pediatr Nephrol 2005;20:1269-72.   DOI   ScienceOn
7 Shin JI, Park JM, Shin YH, Lee JS, Jeong HJ, Kim HS. Serum IgA/C3 ratio may be a useful marker of disease activity in severe Henoch-Schonlein nephritis. Nephron Clin Pract 2005;101:c72-8.   DOI   ScienceOn
8 Hattori M, Ito K, Konomoto T, Kawaguchi H, Yoshioka T, Khono M. Plasmapheresis as the sole therapy for rapidly progressive Henoch-Schonlein purpura nephritis in children. Am J Kidney Dis 1999;33:427-33.   DOI   ScienceOn
9 Scharer K, Krmar R, Querfeld U, Ruder H, Waldherr R, Schaefer F. Clinical outcome of Schonlein-Henoch purpura nephritis in children. Pediatr Nephrol 1999;13:816-23.   DOI   ScienceOn
10 Shin JI, Park JM, Lee JS, Kim JH, Kim PK, Jeong HJ. Successful use of cyclosporin A in severe Schonlein-Henoch nephritis resistant to both methylprednisolone pulse and azathioprine. Clin Rheumatol 2006;25: 759-60.   DOI   ScienceOn
11 Watanabe T, Takahashi S, Nakajo S, Hamasaki M. Pathological improvement of IgA nephropathy and Henoch-Schonlein purpura nephritis with urokinase therapy. Acta Pae diatr Jpn 1996;38:622-8.   DOI
12 Shin JI, Park JM, Shin YH, Kim JH, Kim PK, Lee JS, et al. Cyclosporin A therapy for severe Henoch-Schonlein nephritis with nephrotic syndrome. Pediatr Nephrol 2005; 20:1093-7.   DOI   ScienceOn
13 Algoet C, Proesmans W. Renal biopsy 2-9 years after Henoch-Schonlein purpura. Pediatr Nephrol 2003;18:471-3.
14 Shin JI, Park JM, Shin YH, Kim JH, Lee JS, Jeong HJ. Henoch-Schonlein purpura nephritis with nephrotic-range proteinuria: histological regression possibly associated with cyclosporin A and steroid treatment. Scand J Rheumatol 2005;34:392-5.   DOI   ScienceOn
15 Kawasaki Y, Suzuki J, Suzuki H. Efficacy of methylprednisolone and urokinase pulse therapy combined with or without cyclophosphamide in severe Henoch-Schoenlein nephritis: a clinical and histopathological study. Nephrol Dial Transplant 2004;19: 858-64.   DOI
16 Bergstein J, Leiser J, Andreoli SP. Response of crescentic Henoch-Schoenlein purpura nephritis to corticosteroid and azathioprine therapy. Clin Nephrol 1998;49:9-14.
17 Foster BJ, Bernard C, Drummond KN, Sharma AK. Effective therapy for severe Henoch- Schonlein purpura nephritis with prednisone and azathioprine: a clinical and histopathological study. J Pediatr 2000;136: 370-5.   DOI   ScienceOn
18 Shin JI, Park JM, Shin YH, Kim JH, Lee JS, Kim PK, et al. Can azathioprine and steroids alter the progression of severe Henoch-Schonlein nephritis in children? Pediatr Nephrol 2005;20:1087-92.   DOI   ScienceOn
19 Tanaka H, Suzuki K, Nakahata T, Ito E, Waga S. Early treatment with oral immunosuppressants in severe proteinuric purpura nephritis. Pediatr Nephrol 2003;18:347-50.
20 Oner A, Tinaztepe K, Erdogan O. The effect of triple therapy on rapidly progressive type of Henoch-Schonlein nephritis. Pediatr Nephrol 1995;9:6-10.   DOI   ScienceOn
21 Iijima K, Ito-Kariya S, Nakamura H, Yoshikawa N. Multiple combined therapy for severe Henoch-Schonlein nephritis in children. Pediatr Nephrol 1998;12:244-8.   DOI   ScienceOn
22 Kawasaki Y, Suzuki J, Nozawa R, Suzuki S, Suzuki H. Efficacy of methylprednisolone and urokinase pulse therapy for severe Henoch-Schonlein nephritis. Pediatrics 2003;111:785-9.   DOI   ScienceOn
23 Shin JI, Park JM, Kim JH, Lee JS, Jeong HJ. Factors affecting histological regression of crescentic Henoch-Schonlein nephritis in children. Pediatr Nephrol 2006;21:54-9.   DOI   ScienceOn
24 Niaudet P, Habib R. Methylprednisolone pulse therapy in the treatment of severe forms of Schonlein-Henoch nephritis. Pediatr Nephrol 1998;12:238-43.   DOI   ScienceOn
25 Meadow SR, Glasgow EF, White RHR, Moncrief W, Cameron JS, Ogg CS. Schonlein-Henoch nephritis. Q J Med 1972;41:241-58.
26 Kawasaki Y, Suzuki J, Sakai N, Nemoto K, Nozawa R, Suzuki S, et al. Clinical and pathological features of children with Henoch Schoenlein purpura nephritis: risk factors associated with poor prognosis. Clin Nephrol 2003;60:153-60.   DOI
27 Mir S, Yavascan O, Mutlubas F, Yeniay B, Sonmez F. Clinical outcome in children with Henoch-Schonlein nephritis. Pediatr Nephrol 2007;22:64-70.   DOI   ScienceOn
28 Rieu P, Noel LH. Henoch-Schonlein nephritis in children and adults. Morphological features and clinicopathological correlations. Ann Med Interne (Paris) 1999;150:151-9.
29 Wyatt RJ, Hogg RJ. Evidence-based assessment of treatment options for children with IgA nephropathies. Pediatr Nephrol 2001;16:156-67.   DOI   ScienceOn
30 Yoshikawa N, Tanaka R, Iijima K. Pathophysiology and treatment of IgA nephropathy in children. Pediatr Nephrol 2001;16:446-57.   DOI   ScienceOn
31 Schonlein nephritis: clinical findings related to renal function and morphology. Pediatr Nephrol 2005;20:46-51.   DOI   ScienceOn
32 Ronkainen J, Ala-Houhala M, Huttunen NP, Jahnukainen T, Koskimies O, ormala T, et al. Outcome of Henoch-Schonlein nephritis with nephrotic-range proteinuria. Clin Nephrol 2003;60:80-4.   DOI
33 Ruggenenti P, Schieppati A, Remuzzi G. Progression, remission, regression of chronic renal diseases. Lancet 2001;357:1601-8.   DOI   ScienceOn
34 Kaku Y, Nohara K, Honda S. Renal involvement in Henoch-Schonlein purpura: a multivariate analysis of prognostic factors. Kidney Int 1998;53:1755-9.   DOI   ScienceOn
35 Goldstein AR, White RHR, Akuse R, Chantler C. Long-term follow-up of childhood Henoch- Schönlein nephritis. Lancet 1992;339: 280-2.   DOI   ScienceOn
36 Ronkainen J, Nuutinen M, Koskimies O. The adult kidney 24 years after childhood Henoch-Schonlein purpura. A retrospective cohort study. Lancet 2002;360:666-70.   DOI   ScienceOn
37 Rostoker G. Schonlein-henoch purpura in children and adults: diagnosis, pathophysiology and management. BioDrugs 2001;15: 99-138.   DOI   ScienceOn
38 Sano H, Izumida M, Shimizu H, Ogawa Y. Risk factors of renal involvement and significant proteinuria in Henoch-Schonlein purpura. Eur J Pediatr 2002;161:196-201.   DOI   ScienceOn
39 Davin J-C, Weening JJ. Henoch-Schonlein purpura nephritis: an update. Eur J Pediatr 2001;160:689-95.   DOI
40 Narchi H. Risk of long term renal impairment and duration of follow up recommended for Henoch-Schonlein purpura with normal or minimal urinary findings: a systematic review. Arch Dis Child 2005;90: 916-20.   DOI   ScienceOn
41 Koskimies O, Mir S, Rapola J, Vilska J. Henoch-Schönlein nephritis: long-term prognosis of unselected patients. Arch Dis Child 1981;56:482-4.   DOI   ScienceOn
42 Wortmann SB, Fiselier TJ, Van De Kar NC, Aarts RA, Warris A, Draaisma JM. Refractory severe intestinal vasculitis due to Henoch-Schonlein purpura: successful treatment with plasmapheresis. Acta Paediatr 2006;95:622-3.   DOI   ScienceOn
43 Camacho Diaz JA, Gimenez Llort A, Garcia Garcia L, Jimenez Gonzalez R. Long-term effect of angiotensin-converting inhibitors in children with proteinuria. An Esp Pediatr 2001;55:219-24.   DOI
44 Dixit MP, Dixit NM, Scott K. Managing Henoch-Schonlein purpura in children with fish oil and ACE inhibitor therapy. Nephrology (Carlton) 2004;9:381-6.   DOI   ScienceOn
45 Shin JI, Park JM, Kim JH, Lee JS, Jeong HJ. Methylprednisolone pulse therapy by the Tune-Mendoza protocol in a child with severe Henoch-Schonlein nephritis. Scand J Rheumatol 2006;35:162-3.   DOI   ScienceOn
46 Kawasaki Y, Suzuki J, Murai M, Takahashi A, Isome M, Nozawa R, et al. Plasmapheresis therapy for rapidly progressive Henoch-Schonlein nephritis. Pediatr Nephrol 2004; 19:920-3.
47 Wright E, Dillon MJ, Tullus K. Childhood vasculitis and plasma exchange. Eur J Pediatr 2007;166:145-51.
48 Wen YK, Yang Y, Chang CC. Cerebral vasculitis and intracerebral hemorrhage in Henoch-Schonlein purpura treated with plasmapheresis. Pediatr Nephrol 2005;20: 223-5.   DOI   ScienceOn
49 Yamamoto-Shuda Y, Nakayama K, Saito T, Natori Y. Therapeutic effect of glucocorticoid on experimental crescentic glomerulonephritis. J Lab Clin Med 1999;134:410-8.   DOI   ScienceOn
50 Coppo R, Andrulli S, Amore A, Gianoglio B, Conti G, Peruzzi L, et al. Predictors of outcome in Henoch-Schonlein nephritis in children and adults. Am J Kidney Dis 2006;47: 993-1003   DOI   ScienceOn
51 Chan JC, Trachtman H. Modulating the progression in IgA nephropathy. Nephron Clin Pract 2006;104:c61-8.   DOI   ScienceOn
52 Shin JI, Park JM, Shin YH, Lee JS, Jeong HJ. Role of mesangial fibrinogen deposition in the pathogenesis of crescentic Henoch-Schonlein nephritis in children. J Clin Pathol 2005;58:1147-51.   DOI   ScienceOn